|
|
|
|
||
Strong Buy
Re: Quick question about IVPRPCould the availability of good animal models to do tests in be one of the hurdles to be overcome? many Rare and Orphan diseases were just to expensive in the past to create those animal models. Enter new methods for creating them. SEE SIAL. Advantage SGMO. How important will the manufacturing be to the delivery of the IVPRP products. Edward spends very little time on that issue, but6 it is always a part of almost every med conference intinary. So it must be a major concern, IMO. What is SGMO doing about that? "B" Shares a prtetty dificult to buy below $11.40. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
68625 | The lack of any need for an animal model is a huge advantage for the MGD applications of the IVPR and almost certainly a major reason for SHPG's agreement | zincfinger | 14 | 10/24/2014 1:26:47 PM |